Life Sciences Partners is a venture capital firm specializing in early- to mid-stage life sciences companies.
Phone: 31 20 664 5500
Johannes Vermeerplein 9
Amsterdam, 1071 DV
Netherlands
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-09 | BioClin Therapeutics | Series B - II | $20M | HealthCap Venture Capital, INKEF Capital, Sectoral Asset Management, Sofinnova Ventures, Tekla Capital Management, and Ysios Capital Partners |
| 2018-04-26 | Cardiac Dimensions | Series B | $39M | Aperture Venture Partners, Arboretum Ventures, Hostplus, Lumira Capital, M.H. Carnegie & Co., and Oxford Finance |
| 2018-02-09 | Simplify Medical | Series B - II | $23.25M | M.H. Carnegie & Co., and Sectoral Asset Management |
| 2017-12-11 | Aelin Therapeutics | Series A | $31.86M | Boehringer Ingelheim Venture Fund, Fund+, Novartis Venture Funds, and PMV |
| 2017-11-06 | Nouscom | Series B | $48.65M | 5AM Ventures, Abingworth, and Versant Ventures |
